Inhaled Sirolimus in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Conditions:   Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder);   Chronic Lung Allograft Dysfunction Interventions:   Drug: Sirolimus;   Drug: Placebo Sponsors:   Steven Hays, MD;   AI Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials